These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38744583)

  • 21. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis.
    Kaplan M; Ates I; Akpinar MY; Yuksel M; Kuzu UB; Kacar S; Coskun O; Kayacetin E
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):424-430. PubMed ID: 28823374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey.
    Spatz ES; Canavan ME; Desai MM
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):41-8. PubMed ID: 20031811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of early hypertensive retinopathy to inflammation markers and microalbuminuria in hypertensive patients with regulated blood pressure.
    Ebinc H; Ebinc FA; Ozkurt ZN
    Saudi Med J; 2007 Mar; 28(3):472-3. PubMed ID: 17334487
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial.
    Sever PS; Poulter NR; Chang CL; Hingorani A; Thom SA; Hughes AD; Welsh P; Sattar N;
    Eur Heart J; 2012 Feb; 33(4):486-94. PubMed ID: 21798891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes.
    Waheed S; Matsushita K; Astor BC; Hoogeveen RC; Ballantyne C; Coresh J
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):434-42. PubMed ID: 23258794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.
    Rabkin SW; Langer A; Ur E; Calciu CD; Leiter LA
    Hypertens Res; 2013 Jun; 36(6):550-8. PubMed ID: 23388885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
    Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors for the development of preoperative oxygenation impairment in acute aortic dissection in hypertensive patients.
    Zhao X; Bie M
    BMC Cardiovasc Disord; 2020 Aug; 20(1):365. PubMed ID: 32778051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
    van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey A; de Jong P; Gansevoort RT; ; van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey AS; de Jong PE; Gansevoort RT; Levey A; El-Nahas M; Eckardt KU; Kasiske BL; Ninomiya T; Chalmers J; Macmahon S; Tonelli M; Hemmelgarn B; Sacks F; Curhan G; Collins AJ; Li S; Chen SC; Hawaii Cohort KP; Lee BJ; Ishani A; Neaton J; Svendsen K; Mann JF; Yusuf S; Teo KK; Gao P; Nelson RG; Knowler WC; Bilo HJ; Joosten H; Kleefstra N; Groenier KH; Auguste P; Veldhuis K; Wang Y; Camarata L; Thomas B; Manley T
    Kidney Int; 2011 Jun; 79(12):1341-52. PubMed ID: 21307840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
    Afkarian M; Zelnick LR; Hall YN; Heagerty PJ; Tuttle K; Weiss NS; de Boer IH
    JAMA; 2016 Aug; 316(6):602-10. PubMed ID: 27532915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10 years of follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Cainzos-Achirica M; Miedema MD; McEvoy JW; Cushman M; Dardari Z; Greenland P; Nasir K; Budoff MJ; Al-Mallah MH; Yeboah J; Blumenthal RS; Comin-Colet J; Blaha MJ
    Int J Cardiol; 2018 Aug; 264():158-164. PubMed ID: 29776564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
    Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
    BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence, characteristics, and clinical significance of abnormal albuminuria in patients with hypertension.
    Murai S; Tanaka S; Dohi Y; Kimura G; Ohte N
    Sci Rep; 2014 Jan; 4():3884. PubMed ID: 24457614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between albumin and C-reactive protein and ankle-brachial index in haemodialysis.
    Tsai HJ; Huang JC; Tsai YC; Chen LI; Chen SC; Chang JM; Chen HC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():5-10. PubMed ID: 30298649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The JUPITER trial results boost the evidence for the use of hsCRP as a treatment target and as part of the assessment of vascular risk: time for new guidelines?
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Hellenic J Cardiol; 2009; 50(2):89-91. PubMed ID: 19329409
    [No Abstract]   [Full Text] [Related]  

  • 37. A Population-Based Analysis of Quality Indicators in CKD.
    Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B
    Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide--three new cardiovascular risk markers--do they improve risk prediction and influence treatment?
    Olsen MH; Sehestedt T; Lyngbaek S; Hansen TW; Rasmussen S; Wachtell K; Torp-Pedersen C; Hildebrandt PR; Ibsen H
    Curr Vasc Pharmacol; 2010 Jan; 8(1):134-9. PubMed ID: 19485906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association Between the Aggregate Index of Systemic Inflammation and Albuminuria: A Cross-Sectional Study of National Health and Nutrition Examination Survey 2007-2018].
    Sun L; Huo X; Jia S; Chen X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):671-679. PubMed ID: 38948283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
    Michos ED; Blumenthal RS
    J Am Coll Cardiol; 2009 Mar; 53(11):931-5. PubMed ID: 19281922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.